Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,080.36
+5.68 (+0.53%)
Official Closing Price
Updated: 7:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Why Novo Nordisk Stock Was Melting on Monday
↗
December 08, 2025
It continues to be pounded by competition and challenges coming from numerous directions.
Via
The Motley Fool
Why Did Structure Therapeutics Stock Surge Pre-Market Today?
↗
December 08, 2025
Via
Stocktwits
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar
↗
December 08, 2025
Market-based odds now show an 87% chance of a rate cut.
Via
Stocktwits
Topics
ETFs
Economy
Government
Eli Lilly Scores Huge Win As China Adds Mounjaro To National Insurance — But Raises Fears Of A Brutal Pricing War
↗
December 08, 2025
Eli Lilly and Co (NYSE: LLY) announced that its diabetes drug, Mounjaro, will be added to China's state-run health insurance scheme from January 1, 2026.
Via
Benzinga
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?
↗
December 06, 2025
This is no reason to panic.
Via
The Motley Fool
Topics
Government
ELI LILLY & CO (NYSE:LLY) Offers a High-Quality Dividend Backed by Strong Profitability and Growth
↗
December 06, 2025
Eli Lilly offers a stable, growing dividend backed by exceptional profitability and solid financial health, making it a prime pick for long-term dividend growth investors.
Via
Chartmill
Do These 3 Healthcare Stocks Need a Checkup?
↗
December 05, 2025
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?
Via
The Motley Fool
Topics
Intellectual Property
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028
↗
December 05, 2025
Eli Lilly's stock price and market cap are poised to explode with the GLP-1 market.
Via
The Motley Fool
Topics
Artificial Intelligence
This Pharmaceutical Giant Fell by 10% After a Setback: Time to Sell the Stock?
↗
December 05, 2025
The issues are piling on for the healthcare leader, but this one is nowhere near insurmountable.
Via
The Motley Fool
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026
↗
December 05, 2025
Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Report
↗
December 04, 2025
The report added that at least one of these companies expects to fulfill the multi-billion-dollar investment pledge in full by Jan. 1, 2029.
Via
Stocktwits
Topics
Artificial Intelligence
Government
Workforce
November 2025 Marks Seven Straight Months of Growth with 154 New Industrial Capital Projects
December 04, 2025
JACKSONVILLE BEACH, Fla., Dec. 4, 2025 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads today announced the findings of its November 2025 report on planned capital project spending within the North...
Via
Send2Press
Topics
Artificial Intelligence
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?
December 04, 2025
Despite Agilent Technologies’ underperformance relative to its industry peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Via
Barchart.com
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock?
December 03, 2025
Eli Lilly has decided to slash prices of its weight loss drug Zepbound, making it more accessible to customers.
Via
Barchart.com
Topics
World Trade
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year
↗
December 03, 2025
A key catalyst may be right around the corner.
Via
The Motley Fool
Eli Lilly’s Jaypirca Granted Traditional FDA Approval In Treating Certain Cancers
↗
December 03, 2025
The agency approved the drug for patients who were previously treated with a covalent BTK inhibitor.
Via
Stocktwits
My Top 5 Stocks to Buy Now in December (2025)
↗
December 03, 2025
There is something for everyone in this excellent list of stocks.
Via
The Motley Fool
2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years
↗
December 03, 2025
They are capitalizing on their ability to innovate and rewarding loyal shareholders in the process.
Via
The Motley Fool
Topics
Artificial Intelligence
Navellier Ups Energy Exposure, Increases Argan Position to Over $10 Million
↗
December 02, 2025
AI demand is making energy stocks attractive.
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Regulatory Compliance
The Shifting Tides: How Retail and Institutional Forces Reshape Market Dynamics
December 02, 2025
As of late 2025, the financial markets are in the midst of a profound transformation, driven by the dynamic and often divergent interplay between institutional behemoths and an increasingly empowered...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Fraud
U.S. Stock Market Finds Its Footing: A Cautious Ascent After Tariff Shocks and AI Volatility
December 02, 2025
The U.S. stock market is currently navigating a period of cautious optimism, working to regain solid ground after a tumultuous year marked by significant losses in early 2025 and persistent concerns...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
If You Invested $100 In Eli Lilly Stock 5 Years Ago, You Would Have This Much Today
↗
December 01, 2025
Via
Benzinga
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing
↗
December 01, 2025
Via
MarketBeat
Fundstrat's Tom Lee Predicts S&P 500 Could Climb To 7,300 In December: Report
↗
December 01, 2025
Lee also cited the end of the Federal Reserve’s quantitative tightening program, effective December 1, as a tailwind for U.S. equity markets.
Via
Stocktwits
Topics
Economy
Stocks
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy
↗
December 01, 2025
Patients can buy Zepbound at these prices through the company’s direct-to-consumer platform, LillyDirect.
Via
Stocktwits
Topics
Economy
Government
Trillion-Dollar Companies Now Go To 11; Google Is No. 3
↗
December 01, 2025
Eli Lilly recently gained a trillion-dollar valuation. S&P 500 titans Nvidia leads
Via
Investor's Business Daily
Topics
Stocks
Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know.
↗
December 01, 2025
A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a reset for long-term opportunity?
Via
The Motley Fool
Is the Vanguard Dividend Appreciation ETF a Buy Now?
↗
December 01, 2025
The Vanguard Dividend Appreciation ETF is a popular choice among dividend investors.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Walmart Will Make Stock Market History on Dec. 9 -- and It Can Top This Feat in 2026
↗
December 01, 2025
The puzzle pieces are in place for the world's largest retailer by revenue to reach a milestone in 2026 that only a dozen public companies globally have achieved.
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
Economy
3 Vanguard ETFs to Buy and Hold for the Long Haul
↗
November 30, 2025
These stocks can be set-it-and-forget-it holdings for most investors.
Via
The Motley Fool
Topics
ETFs
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
